0001144204-16-106812.txt : 20160603
0001144204-16-106812.hdr.sgml : 20160603
20160603170142
ACCESSION NUMBER: 0001144204-16-106812
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160602
FILED AS OF DATE: 20160603
DATE AS OF CHANGE: 20160603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000895051
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581959440
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-864-2600
MAIL ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ENTREMED INC
DATE OF NAME CHANGE: 19960415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ren Ken Keyong
CENTRAL INDEX KEY: 0001545181
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20713
FILM NUMBER: 161696508
MAIL ADDRESS:
STREET 1: 9640 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
v441728_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-06-02
0
0000895051
CASI Pharmaceuticals, Inc.
CASI
0001545181
Ren Ken Keyong
CASI PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DRIVE, SUITE 300
ROCKVILLE
MD
20850
1
1
0
0
Chief Executive Officer
Stock Options (Right to Buy)
0.8601
2016-06-02
4
A
0
280701
0
A
2016-06-02
2026-03-11
Common Stock
280701
280701
D
The option grant was approved by the Board of Directors on March 11, 2016, subject to stockholder approval of amendments to the 2011 Long-Term Incentive Plan (the "Amendments"). The Company's stockholders approved the Amendments on June 2, 2016.
/s/ Cynthia W. Hu, attorney-in-fact for Ken K. Ren
2016-06-03